Long term home parenteral nutrition or small bowel transplantation? Florence LACAILLE Necker-enfants malades, Paris

Similar documents
ESPEN Congress Brussels 2005 INDICATIONS FOR INTESTINAL TRANSPLANTATION. Loris Pironi

Advances in intestinal Rehabilitation Susan Hill Gastroenterology Consultant

INTESTINAL FAILURE, REHABILITATION & TRANSPLANTATION: Indications, Techniques and Outcomes

Small bowel and Multivisceral Transplantation

Intestinal Rehabilitation and Transplantation

LA CHIRURGIA RIABILITATIVA

Nutrition Management in GI Diseases

Corporate Medical Policy

ESPEN Congress Geneva 2014 NUTRITION IN PAEDIATRIC PATIENTS 2. Nutrition treatment in children with intestinal failure S.

Management of Short Bowel Syndrome in the Era of Teduglutide. Charlene Compher, PhD, RD University of Pennsylvania

Surgery for Intestinal Failure

Isolated Liver Transplantation in Infants with End-Stage Liver Disease Due to Short Bowel Syndrome

Gastroschisis Sequelae and Management

Nutritional Requirements in Intestinal Failure

Current Trends in Home Parenteral Nutrition

Sustain Follow-up Data Collection Form (Revised 2/4/2014) (both pediatric and adult elements) (Please select) (Please select)

Heart Transplantation for Patients with a Fontan Procedure

Improved survival in a multidisciplinary short bowel syndrome program

Small Bowel Transplant

Clinical Improvement Following Home Parenteral Nutrition in Pediatric Patients with Intestinal Failure

Who Needs Parenteral Nutrition? Is Parenteral Nutrition An Appropriate Intervention?

Follow-up Forms-Pediatric Data Collection Tools A.S.P.E.N.

Live Donor Small Bowel Transplantation. Enrico Benedetti, MD, FACS Warren H. Cole Chair in Surgery Professor and Head Department of Surgery

Intestinal Transplantation. Cristiano Quintini, MD Intestinal Rehabilitation and Transplant Program Cleveland Clinic

Pathology of Intestinal Obstruction. Dr. M. Madhavan, MBBS., MD., MIAC, Professor of Pathology Saveetha Medical College

NHS BLOOD AND TRANSPLANT BOWEL ADVISORY GROUP PATIENT SURVIVAL AFTER INTESTINAL TRANSPLANT

Observations 1251 Variables 207

PARENTERAL NUTRITION- ASSOCIATED LIVER DISEASE IN CHILDREN

Effect of changing lipid formulation in Parenteral Nutrition in the Newborn Experimental Pathology BSc

Isolated Small Bowel Transplant. Populations Interventions Comparators Outcomes Individuals: With intestinal failure

SUSTAIN BASELINE DATA COLLECTION FORM. Revised 2/4/2014 (both pediatric and adult data elements) 1. Gestational age at birth ( weeks gestation)

Short Bowel Syndrome: Medical management

Recipients and Recipient Transplant Coordinators. April 2014 Helen Tincknell Lead Nurse Recipient Coordination NHSBT

Ontario s Paediatric Referral and Listing Criteria for Small Bowel and Liver- Small Bowel Transplantation

Total Parenteral Nutrition and Enteral Nutrition in the Home. Original Policy Date 12:2013

multivis ce Regulations, te 2.0

Nutritional Support in Paediatric Patients (1) Topic 4

Heart Transplantation ACC Middle East Conference Dubai UAE October 21, 2017

Daniel Hirsch, MD Director of Neonatology Somerset Medical Center Assistant Professor of Pediatrics UMDNJ RWJMS

Medical Policy. MP Parenteral, Enteral and Oral Nutrition in The Home. Related Policies None

Baseline Forms- Pediatric Data Collection Tools A.S. P. E. N.

Subject: Small Bowel Transplantation, Small Bowel and Liver Transplantation and Multivisceral Transplantation. Original Effective Date: 8/30/2012

ESPEN Congress Florence 2008

Acute kidney injury after neonatal heart surgery, prevention and management

Isolated Small Bowel Transplant

CHILDREN: NUTRITIONALS Prescription Required Provided by the Wisconsin WIC Program to Children (1 through 4 Years of Age)

Fistuloclysis (distal limb feeding) Dr Alison Culkin Research Dietitian AuSPEN 2015

Gastroenterology. Certification Examination Blueprint. Purpose of the exam

2016 Outcomes Report. Liver & Intestinal Transplant Program

Medical Policy. MP Isolated Small Bowel Transplant

Summary of Significant Changes. Policy

SHORT GUT SYNDROME (SGS) : A MANAGEMENT CHALLENGE!

Clinical Policy: Total Parenteral Nutrition and Intradialytic Parenteral Nutrition

Clinical Policy: Intestinal and Multivisceral Transplant

GASTROENTEROLOGY Maintenance of Certification (MOC) Examination Blueprint

Isolated Small Bowel Transplant

Helping transplant patients embrace new lives.

Fish oil based lipid emulsion s role in transitioning pediatric patients from plant based to combination plant and fish oil based lipid emulsion

Chronic Intractable Diarrhoea of infancy

Managing abnormal LFTs

ICU NUTRITION UPDATE : ESPEN GUIDELINES Mirey Karavetian Assistant Professor Zayed University

ESPEN Congress Copenhagen 2016

LEARNING RESOURCES. 1. Anatomy: Gross Anatomy of The Liver and Gall Bladder Study from: Essential Moore, 5 th Ed., Pages: DEMO note.

The Meat and Potatoes of Critical Care Nutrition ROSEMARY KOZAR MD PHD SHOCK TRAUMA UNIVERSITY OF MARYLAND

ESPEN Congress Florence 2008

LIST OF CLINICAL PRIVILEGES DIETITIAN

Small Bowel/Liver and Multivisceral Transplant

GI Potpourri Washington State Academy of Nutrition and Dietetics

Dietary management. Dr Alison Culkin Lead Intestinal Failure Dietitian St Mark s Hospital RSM December 2017

LONG-TERM PARENTERAL NUTRITIONAL SUPPORT AND INTESTINAL ADAPTATION IN CHILDREN WITH SHORT BOWEL SYNDROME: A 25-YEAR EXPERIENCE

Clinical Policy: Total Parenteral Nutrition and Intradialytic Parenteral Nutrition Reference Number: CP.PHAR.205

Nutritional Support outside the Hospital: Home Parenteral Nutrition (HPN) in Adult Patients Topic 19

Strategies to Reduce Catheter-Related Bloodstream Infections in Pediatric Patients Receiving Home Parenteral Nutrition:

Strategies for preventing and treating IFALD

Index. Note: Page numbers of article titles are in boldface type.

Replacement of the Ascending Aorta in Early Childhood: Surgical Strategies and Long-Term Outcome

Specialised Services Policy: CP24 Home Administered Parenteral Nutrition (HPN)

Safety and Efficacy of Teduglutide After 52 Weeks of Treatment in Patients With Short Bowel Syndrome Intestinal Failure

JINNAH SINDH MEDICAL UNIVERSITY

Roundtable Presentation Hirschsprung s Disease

Intestinal transplantation: evolution and current status

Transplantable Organs

FEP Medical Policy Manual

MCT AND THE ROLES NUTRITION

What s s up with Omegaven????? Kathleen Gura PharmD Children s s Hospital Boston

Populations Interventions Comparators Outcomes Individuals: With intestinal failure and evidence of impending endstage. are: are:

Citrulline as a marker of intestinal function and absorption in clinical settings: a systematic review and meta-analysis

Sheila E. Crowe, MD, FRCPC, FACP, FACG, AGAF Department of Medicine University of California, San Diego

Małgorzata Łyszkowska

Hepatoprotective Therapies for TPN-Associated Cholestasis

Original Policy Date

OST575 Course Schedule US2017

2017 Outcomes Report. Liver & Intestinal Transplant Program

PARENTS OF STOMA CHILDREN.

Gut failure in neuro-disability: a paediatric centre experience

RECTAL PROLAPSE objectives

Level 2. Non Responsive Celiac Disease KEY POINTS:

Hirschprung s. Meconium plug R/S >1 R/S <1

Current concepts in Critical Care Nutrition

Nutritional Issues in Cholestatic Disease

Transcription:

Long term home parenteral nutrition or small bowel transplantation? Florence LACAILLE Necker-enfants malades, Paris

Intestinal failure : definitive Ultra-short bowel : ± < 30 cm - valve ± < 20 cm + valve Microvillous atrophy Long segment Hirschsprung disease (= total aganglionosis) Tufting enteropathy?

Intestinal failure : not definitive? Short bowel 40 -> 80 cm : adaptation ; lengthening? Tufting enteropathy a few weaned from PN CIPOS nursing, surgery ; prognosis?

First goal of care = feed the child Parenteral nutrition sustain growth and development promote intestinal adaptation no additional complications Bridge to adaptation and normal function Long term treatment

What is the future? Long term parenteral nutrition transplantation only if complications PN as a bridge for small bowel transplantation

Survival on home PN / indication Colomb V et al, 302 patients, Necker-EM, 1980-99

Prognosis : Necker 1980-2000, n=302 SBS Diarrhea CIPOS IBD Imm.def Weaned 61 12 32 85 46 Death 7 24 13 3 39 Transplant 6 16 3 0 0 Still on PN 26 48 52 12 15

SBS : weaning off PN 2000-2010 Median : 19 months Negative factors Univariate o length of the remnant bowel < 40 cm o absence of ICV, colon < 50% o IV Lipid > 1.5g/kg/d, PN caloric >70% Multivariate : length of remnant bowel < 40 cm

Complications of home PN Home PN is impossible Extensive vascular thrombosis Multiple infections Progressive IF-associated liver disease Growth failure Psychological intolerance / HPN

Complications of home PN Home PN is impossible Extensive vascular thrombosis Multiple infections Progressive IF-associated liver disease Growth failure Psychological intolerance / HPN

Home PN impossible? The aim of our meeting!! Social and psychological help Limits : long term hospitalization microvillous atrophy : unstability ++ = early indication

Complications of home PN Home PN is impossible Extensive vascular thrombosis Multiple infections Progressive IF-associated liver disease Growth failure Psychological intolerance / HPN

Vascular thrombosis? Controlled size and position of central lines Limits : elsewhere 2 thrombosis Do not wait for the last central line

superior and inferior cave thrombosis Transliver KT Just one left subclaviar vein Under-renal thrombosis

Complications of home PN Home PN is impossible Extensive vascular thrombosis Multiple infections Progressive IF-associated liver disease Growth failure Psychological intolerance / HPN

Infections? Staff and caregiver training Taurolidine / ethanol locks Limits : diarrhea ++ child s behaviour hospitalization elsewhere

Complications of home PN Home PN is impossible Extensive vascular thrombosis Multiple infections Progressive IF-associated liver disease Growth failure Psychological intolerance / HPN

Progressive liver disease? Control of risk factors + fish oil Limits : elsewhere sometimes it does not work Necker : +/- 110 children home PN (40% France) 2 end-stage liver diseases in last 10 years

Mortality on long term PN = 16 % 9 % : digestive disease 38 % : other (AIDS ) Cause original disease : 62 % infection : 11 % liver : 12 % other : 15 % Necker-EM 302 patients

IF-associated liver disease is reversible (without fish oil) Liver 1999 99-2002 : home PN Liver 2002

Complications of home PN Home PN is impossible Extensive vascular thrombosis Multiple infections Progressive IF-associated liver disease Growth failure Psychological intolerance / HPN

Growth? Adapted nutrients and energy Limits : liver?

Complications of home PN Home PN is impossible Extensive vascular thrombosis Multiple infections Progressive IF-associated liver disease Growth failure Psychological intolerance / HPN

Psychological intolerance? Discuss risks! Psychological help But : you do not understand before being in intolerance may => complications less care?

Home PN versus Tx HPN ------------------------------------------------- HPN ----------------- // Tx -------------------------------------.. >

Small bowel Tx : indications Total AND definitive intestinal failure AND complications of home PN Do not wait for major complications!!! Waiting time

Number of Transplants Intestinal Transplants Performed 250 200 150 100 50 0 1985 1987 1989 1991 1993 1995 1997 1999 2001 2003 2005 2007 2009 2011 2013 Year of Transplant Children Adults

Indications Children Retransplant 8% Other 5% Tumor 1% Motility Disorder 19% Short Gut 63% Volvulus 16% Gastroschisis 21% Trauma 1% N. Enterocolitis 12% Malabsorption 9% Other Short Gut 3% Ischemia 1% Atresia 4% Intestinal Transplant Registry Report 2015

Necker : 1987-9, 1994-2015 - 9 children - 102 children, 111 transplantations short bowel : 35 congenital enteropathy : 35 motility disorder : 28 re-transplantation : 10

Necker-EM : 1994 2014 102 children, 111 transplantations Age at Tx : +/- 4.5 y 59 : isolated small bowel Tx 44 : combined-liver small bowel 4 multivisceral Tx, 1 modified multivisceral Tx + colon : 67

Which type of transplantation? Isolated small bowel Tx vs combined liver-sb Tx more organes less early mortality less early rejection less late graft losses <=> liver protects intestine?

Do a liver biopsy Normal --> F2 Isolated small bowel Control risk factors +++ Biopsy / 6-12 months F3-4 + liver

Type of transplantation Isolated small bowel Tx short bowel syndrome Small bowel + colon congenital enteropathy motility disorder Small bowel + colon + stomach (+ pancreas) CIPOS, very long-segment Hirschsprung

Type of transplantation Liver + small bowel Tx idem small bowel + severe fibrosis Multivisceral motility disorder + severe fibrosis

Difficult discussions Isolated liver transplantation ESLD + SBS + normal morphology realistic expectation of gut adaptation o previous enteral tolerance : 50 % o age < 4 y

Small bowel transplantation Oldest survivor with graft : French, born 1988, Tx 1989 Most patients : < 15 y F/U Risks and complications many!!! Long-term : % late graft loss?

Graft Survival by Era Children Adults p=<0.001 p=<0.001 2006-2014 2000-2005 2000-2005 1985-1999

Patient survival by transplant type : children (2009-2014) SB+Liver SB MVT MMVT

Graft survival by transplant type : children (2009-2014) SB+Liver SB MVT MMVT

Functional Status (Patients Transplanted 2009 2014 who have survived at least 6 months) Freedom from PN Modified Karnofsky Performance Scores 100% 100% 90% 90% 80% 80% 70% 70% 60% 60% 50% 50% 40% 40% 30% 30% 20% 20% 10% 10% 0% Adults Children 0% Adults Children Full Function IV Fluids No Function Unknown 90%-100% 61%-89% 31%-60% 1%-30% Unknown

Necker : 1987-9, 1994-2016 40 patients with graft off PN, +/- enteral nutrition 17 returned to PN 5 patients on the waiting list

In conclusion 2016 : long term PN best prognosis if PN in intestinal failure centre If you must transplant : do not wait for major complications will be EVEN MORE difficult More children die early after L-SBTx More grafts survive late after L-SBTx

Teşekkür ederim!